Integrative Tumor Board: Pancreatic Cancer Physical Therapy
نویسندگان
چکیده
منابع مشابه
Integrative tumor board: Advanced breast cancer.
1. The Challenge Recurrent breast cancer with post-surgery metastasis to bone (BCMB) is a problematic challenge to the medical field. Clinically, there has been no effective treatment or therapy available for this particular cancer condition. The first author has helped 18 cases of BCMB since his appointment as director of the National Qigong Anti-Cancer Research Project in China in the early 1...
متن کاملIntegrative tumor board: transitional cell carcinoma of the bladder.
• In this case, we are presented with a 70 year old male retired insurance executive, 35 pack-year smoker, with no other environmental exposure risks, but with a history of lithotripsy for renal stones, and with non-invasive papillary transitional cell carcinoma (TCC) in the right ureter and bladder (at least 2 sites). The patient presented with hematuria, right flank pain, urinary urgency and ...
متن کاملgastrointestinal tumor board: an evolving experience in tehran cancer institute.
gastrointestinal (gi) cancers are a significant source of morbidity and mortality in iran, with stomach adenocarcinoma as the most common cancer in men and the second common cancer in women. also, some parts of northern iran have one of the highest incidences of esophageal cancer in the world. multi-disciplinary organ-based joint clinics and tumor boards are a well-recognized necessity for mode...
متن کاملNanotechnologies in Pancreatic Cancer Therapy
Pancreatic cancer has been classified as a cancer of unmet need. After diagnosis the patient prognosis is dismal with few surviving over 5 years. Treatment regimes are highly patient variable and often the patients are too sick to undergo surgical resection or chemotherapy. These chemotherapies are not effective often because patients are diagnosed at late stages and tumour metastasis has occur...
متن کاملAdjuvant therapy of pancreatic cancer.
Adjuvant therapy for pancreatic cancer remains controversial. However, both sides of the Atlantic Ocean agree that at least gemcitabine should be the pivotal agent offered to all patients. The role of radiation therapy remains somewhat inconclusive but chemoradiation, whether in the neoadjuvant or adjuvant setting is a standard option often utilized in the USA. This review is an update from the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Integrative Cancer Therapies
سال: 2008
ISSN: 1534-7354,1552-695X
DOI: 10.1177/1534735408319067